We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTargeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer.AuthorsLehmann, Sören; Bykov, Vladimir J. N.; Ali, Dina; Andrén, Ove; Cherif, Honar; Tidefelt, Ulf; Uggla, Bertil; Yachnin, Jeffrey; Juliusson, Gunnar; Moshfegh, Ali; Paul, Christer; Wiman, Klas G.; Andersson, Per-OlaPublicationJournal of Clinical Oncology, 2012, Vol 30, Issue 29, p3633ISSN0732-183xPublication typearticleDOI10.1200/JCO.2011.40.7783